MedTrace Logo

Insulin Resistance Study

NCT00614757 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2012-10-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate how often patients with hepatitis C infection have abnormalities of sugar and fat utilization. Additionally we would like to find out if these abnormalities of sugar and fat utilization are common in other liver diseases, or related to being overweight.

Conditions

Interventions

DRUG

N-acetylcysteine 20% 4ml

N-acetylcysteine 20% 4ml

DRUG

N-acetylcysteine 20% in 4 ml

N-acetylcysteine 20% in 4 ml

Sponsors & Collaborators

  • Midwest Biomedical Research Foundation

    lead OTHER

Principal Investigators

  • Prashant K Pandya, DO · Kansas City VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00614757 on ClinicalTrials.gov